Ahead of CME (CME) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Wall Street analysts expect CME Group (CME) to post quarterly earnings of $2.44 per share in its upcoming report, which indicates a year-over-year increase of 3%. Revenues are expected to be $1.51 billion, up 4.6% from the year-ago quarter.The consensus EPS estimate for the quarter has undergone an upward revision of 0.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.With that in mind, let's delve into the average projections of some CME metrics that are commonly tracked and projected by analysts on Wall Street.Based on the collective assessment of analysts, 'Revenues- Other' should arrive at $111.83 million. The estimate indicates a year-over-year change of +27.7%.The combined assessment of analysts suggests that 'Revenues- Clearing and transaction fees' will likely reach $1.21 billion. The estimate points to a change of +2.4% from the year-ago quarter.The collective assessment of analysts points to an estimated 'Revenues- Market data and information services' of $180.38 million. The estimate indicates a change of +7.9% from the prior-year quarter.Analysts expect 'Revenues- Clearing and transaction fees - Interest rates' to come in at $403.11 million. The estimate points to a change of -1.7% from the year-ago quarter.The consensus among analysts is that 'Revenues- Clearing and transaction fees - Foreign exchange' will reach $46.90 million. The estimate points to a change of -8.2% from the year-ago quarter.Analysts' assessment points toward 'Average daily volume (including NYMEX and COMEX)' reaching 25.47 million. Compared to the current estimate, the company reported 25.51 million in the same quarter of the previous year.Analysts forecast 'Average daily volume - Metals (including NYMEX and COMEX)' to reach 672.93 thousand. Compared to the present estimate, the company reported 609 thousand in the same quarter last year.The consensus estimate for 'Average daily volume - Interest rates (including NYMEX and COMEX)' stands at 13.24 million. The estimate is in contrast to the year-ago figure of 13.35 million.According to the collective judgment of analysts, 'Average daily volume - Equity indexes (including NYMEX and COMEX)' should come in at 6.31 million. Compared to the present estimate, the company reported 6.92 million in the same quarter last year.Analysts predict that the 'Average daily volume - Foreign exchange (including NYMEX and COMEX)' will reach 969.14 thousand. The estimate compares to the year-ago value of 1.01 million.It is projected by analysts that the 'Average daily volume - Energy (including NYMEX and COMEX)' will reach 2.52 million. Compared to the current estimate, the company reported 2.16 million in the same quarter of the previous year.The average prediction of analysts places 'Average daily volume - Agricultural commodities (including NYMEX and COMEX)' at 1.76 million. The estimate is in contrast to the year-ago figure of 1.47 million.View all Key Company Metrics for CME here>>>Shares of CME have experienced a change of +6.6% in the past month compared to the +1.9% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), CME is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Free Today: Profiting from The Future’s Brightest Energy SourceThe demand for electricity is growing exponentially. At the same time, we’re working to reduce our dependence on fossil fuels like oil and natural gas. Nuclear energy is an ideal replacement.Leaders from the US and 21 other countries recently committed to TRIPLING the world’s nuclear energy capacities. This aggressive transition could mean tremendous profits for nuclear-related stocks – and investors who get in on the action early enough.Our urgent report, Atomic Opportunity: Nuclear Energy's Comeback, explores the key players and technologies driving this opportunity, including 3 standout stocks poised to benefit the most.Download Atomic Opportunity: Nuclear Energy's Comeback free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CME Group Inc. (CME): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks